Evidence map›Paper›PMID 14532152›Full record

ReviewAnnals of the rheumatic diseases2003

Angiogenesis as a target in rheumatoid arthritis.

A E Koch

Abstract readReview
In one paragraph

Review in Annals of the rheumatic diseases, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Cervical Pannus Without Rheumatoid Arthritis or Trauma.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Comparative Evaluation ofContrast media & molecular imaging · 2019
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A E KochFeinberg School of Medicine, Northwestern University and Veteran's Administration Chicago Healthcare System, Lakeside Division, IL 60611, USA. ae-koch@nwu.edu

Funding

IL 4 AND IL 13 GENE THERAPY FOR ARTHRITISR01AI040987 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOCH, ALISA E · 1998 to 2006
$1.3M
NOVEL ANGIOGENIC CYTOKINE INDUCED ENDOTHELIAL ANTIGENR01HL058695 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOCH, ALISA E · 1999 to 2002
$640k
IL 4 AND IL 13 GENE THERAPY FOR ARTHRITISR21AI040987 · NIAID · NORTHWESTERN UNIVERSITY · PI KOCH, ALISA E · 1997 to 1997
–
NHLBI NIH HHS HL58695NIAID NIH HHS AI40987
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAngiogenic ProteinsAnimalsAntirheumatic AgentsArthritis, RheumatoidHumansMiceNeovascularization, PathologicSynovial MembraneAngiogenesis InhibitorsAngiogenic ProteinsAntirheumatic Agents

Identifiers

PMID14532152
PMCPMC1766740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.